120 related articles for article (PubMed ID: 22738631)
21. Farnesyltransferase pharmacophore model derived from diverse classes of inhibitors.
Lu A; Zhang J; Yin X; Luo X; Jiang H
Bioorg Med Chem Lett; 2007 Jan; 17(1):243-9. PubMed ID: 17049856
[TBL] [Abstract][Full Text] [Related]
22. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
[TBL] [Abstract][Full Text] [Related]
23. Structural feature study of benzofuran derivatives as farnesyltransferase inhibitors.
Moorthy NS; Sousa SF; Ramos MJ; Fernandes PA
J Enzyme Inhib Med Chem; 2011 Dec; 26(6):777-91. PubMed ID: 21381884
[TBL] [Abstract][Full Text] [Related]
24. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
[TBL] [Abstract][Full Text] [Related]
25. Farnesyltransferase inhibitors: CAAX mimetics based on different biaryl scaffolds.
Straniero V; Pallavicini M; Chiodini G; Ruggeri P; Fumagalli L; Bolchi C; Corsini A; Ferri N; Ricci C; Valoti E
Bioorg Med Chem Lett; 2014 Jul; 24(13):2924-7. PubMed ID: 24821376
[TBL] [Abstract][Full Text] [Related]
26. 7-imidazolylalkanamido-1-carboxylalkylbenzo-diazepine, a novel series of farnesyltransferase inhibitors.
Wan SB; Chu FM; Guo ZR
Yao Xue Xue Bao; 2002 Jul; 37(7):516-21. PubMed ID: 12914320
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and antifungal activity of some substituted phenothiazines and related compounds.
Sarmiento GP; Vitale RG; Afeltra J; Moltrasio GY; Moglioni AG
Eur J Med Chem; 2011 Jan; 46(1):101-5. PubMed ID: 21093111
[TBL] [Abstract][Full Text] [Related]
28. Surfing the piperazine core of tricyclic farnesyltransferase inhibitors.
Rokosz LL; Huang CY; Reader JC; Stauffer TM; Chelsky D; Sigal NH; Ganguly AK; Baldwin JJ
Bioorg Med Chem Lett; 2005 Dec; 15(24):5537-43. PubMed ID: 16202593
[TBL] [Abstract][Full Text] [Related]
29. Pharmacophore mapping of diverse classes of farnesyltransferase inhibitors.
Equbal T; Silakari O; Rambabu G; Ravikumar M
Bioorg Med Chem Lett; 2007 Mar; 17(6):1594-600. PubMed ID: 17236767
[TBL] [Abstract][Full Text] [Related]
30. 2,3-Disubstituted-1,4-naphthoquinones, 12H-benzo[b]phenothiazine-6,11-diones and related compounds: synthesis and biological evaluation as potential antiproliferative and antifungal agents.
Tandon VK; Maurya HK; Tripathi A; ShivaKeshava GB; Shukla PK; Srivastava P; Panda D
Eur J Med Chem; 2009 Mar; 44(3):1086-92. PubMed ID: 18708272
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of phenothiazine derivatives as potential inhibitors of phospholipase C.
Brufani M; Cesta MC; Filocamo L; Lappa S; Marta M; Pomponi M; Meroni C; Pagella PG
Farmaco; 1992 May; 47(5):585-97. PubMed ID: 1388603
[TBL] [Abstract][Full Text] [Related]
32. Structure-activity relationship studies on thiaplidiaquinones A and B as novel inhibitors of Plasmodium falciparum and farnesyltransferase.
Cadelis MM; Bourguet-Kondracki ML; Dubois J; Kaiser M; Brunel JM; Barker D; Copp BR
Bioorg Med Chem; 2017 Aug; 25(16):4433-4443. PubMed ID: 28666857
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and biological evaluation of substituted dioxodibenzothiazepines and dibenzocycloheptanes as farnesyltransferase inhibitors.
Gilleron P; Wlodarczyk N; Houssin R; Farce A; Laconde G; Goossens JF; Lemoine A; Pommery N; Hénichart JP; Millet R
Bioorg Med Chem Lett; 2007 Oct; 17(19):5465-71. PubMed ID: 17827015
[TBL] [Abstract][Full Text] [Related]
34. Phenothiazine: the seven lives of pharmacology's first lead structure.
Ohlow MJ; Moosmann B
Drug Discov Today; 2011 Feb; 16(3-4):119-31. PubMed ID: 21237283
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and biological activity of 4-[(4-cyano-2-arylbenzyloxy)-(3-methyl-3H-imidazol-4-yl)methyl]benzonitriles as potent and selective farnesyltransferase inhibitors.
Wang L; Wang GT; Wang X; Tong Y; Sullivan G; Park D; Leonard NM; Li Q; Cohen J; Gu WZ; Zhang H; Bauch JL; Jakob CG; Hutchins CW; Stoll VS; Marsh K; Rosenberg SH; Sham HL; Lin NH
J Med Chem; 2004 Jan; 47(3):612-26. PubMed ID: 14736242
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, biochemical, and cellular evaluation of farnesyl monophosphate prodrugs as farnesyltransferase inhibitors.
Clark MK; Scott SA; Wojtkowiak J; Chirco R; Mathieu P; Reiners JJ; Mattingly RR; Borch RF; Gibbs RA
J Med Chem; 2007 Jul; 50(14):3274-82. PubMed ID: 17555307
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of farnesyltransferase reduces angiogenesis by interrupting endothelial cell migration.
Peng G; Ren Y; Sun X; Zhou J; Li D
Biochem Pharmacol; 2012 May; 83(10):1374-82. PubMed ID: 22382068
[TBL] [Abstract][Full Text] [Related]
38. Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives.
Bisi A; Meli M; Gobbi S; Rampa A; Tolomeo M; Dusonchet L
Bioorg Med Chem; 2008 Jul; 16(13):6474-82. PubMed ID: 18522868
[TBL] [Abstract][Full Text] [Related]
39. A novel inhibitor of farnesyltransferase with a zinc site recognition moiety and a farnesyl group.
Tanaka A; Radwan MO; Hamasaki A; Ejima A; Obata E; Koga R; Tateishi H; Okamoto Y; Fujita M; Nakao M; Umezawa K; Tamanoi F; Otsuka M
Bioorg Med Chem Lett; 2017 Aug; 27(16):3862-3866. PubMed ID: 28666734
[TBL] [Abstract][Full Text] [Related]
40. Antitumor Activity of PEGylated and TEGylated Phenothiazine Derivatives: Structure-Activity Relationship.
Cibotaru S; Sandu AI; Nicolescu A; Marin L
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
